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Received 12 December 2014; revised 20 December 2014; accepted 9 January 2015AbstractMigraine, a moderate to severe chronic headache occurring on one or both sides, is a common disease affects young people. Although hearing
loss in subjects with migraine is not rare, the correlation of migraine with hearing loss is not clear. In this study, we examined hearing loss in
young migraine subjects to determine if migraine may be a factor in causing cochlear dysfunction. Seven college students with migraine and
three age matched subjects without history of migraine were assessed using extended high frequency audiometry and distortion product
otoacoustic emissions (DPOAEs). There was no significant difference in regular audiometry threshold between the migraine group and the
control group. However, high frequency audiometry (9e16 kHz) showed thresholds at 25 dB nHL or higher in six out of twenty ears in the
migraine group. The amplitude of DPOAEs were reduced for more than 10 dB in the migraine group in comparison with the control group.
These data suggest that migraine may affect cochlear dysfunction evidenced by the reduced amplitude of DPOAE and high frequency pure-tone
audiometry.
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(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Migraine is moderate to severe chronic headache which can
occur on one or both sides of the head. The symptom of
migraine can be exacerbated by physical movement. A head-
ache must have at least two of the following characteristics for
migraine: unilateral location, pulsating quality, moderate or
severe pain intensity, and aggravation by routine physical ac-
tivity. Additionally, during the course of the headache, patients
have at least one of the following: nausea with/without vom-
iting, photophobia, and phonophobia. Most migraine sufferers
experience the following symptoms during or two days prior
the onset of a migraine: flashes of light, nausea, unusual
sensitivity to light and sound, tingling in the limbs, cravings* Corresponding author. Tel.: þ1 716 8295307.
E-mail address: weisun@buffalo.edu (W. Sun).
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Ltd. This is an open access article under the CC BY-NC-ND license (http://creativfor sweets, drowsiness, extreme thirst, intense energy, fatigue,
sweating, and irritability or depression. A migraine is known
to last for short durations such as a couple hours up or longer
periods of up to five days. Sometimes the symptoms can be so
disabling that the individual cannot attend to normal daily
activities. According to a 2001 report by the National Institute
of Neurological Disorders and Stroke, more than 28 million
people in the United States experience migraines. Statistical
data reported by the Centers for Disease Control and Pre-
vention (CDC) indicate that females have higher incidence
than males of migraine or severe headache (Pleis et al., 2010).
Adults aged 18e44 years are almost three times as likely as
adults 65 years or older to experience migraines and it is
known to run in families (Olsen and Lipton, 2004).
It is unclear exactly what causes migraine. Migraine may be
caused by abnormal brain activity that is caused by stress,
particular foods, environmental or unknown factors. A large
number of medical experts now think themigraine attack begins
in the brain, and includes a mixture of nerve pathways andy Head and Neck Surgery. Production and hosting by Elsevier (Singapore) Pte
ecommons.org/licenses/by-nc-nd/4.0/).
170 L. Cameron, W. Sun / Journal of Otology 9 (2014) 169e172chemicals. These changes are thought to influence blood flow in
the brain and neighboring tissues (Caplan, 1991). Previously,
researchers have linked migraines to blood vessel dilation and
constriction in the head (Caplan, 1991). Recent theories from
scientists now think migraine may be caused by genetic ab-
normalities in particular cell populations in the brain. Interest-
ingly, some individuals have also experienced a temporary
sudden increase of hearing threshold (Viirre and Baloh, 1996).
This leads to concerns that it may be a sign of further damage
that could be happening in the inner ear. Lipkin et al. (1987)
described a patient with sudden sensorineural hearing loss
connected with typical migraine headache. Caplan (1991)
described a sudden onset of a unilateral hearing loss and aural
fullness as the preceding symptom of a cerebellar infarct in a
patient who had migraine with visual aura and basilar artery
stenosis. Viirre and Baloh (1996) described 13 patients with
unexplained sudden hearing loss and neurological symptoms,
all of whom had long-standing migraine headaches. Lee et al.
(2000) described a patient with long-standing migraine with
aura who experienced sudden hearing loss at the age of 50 years
and onset of Meniere's syndrome at the age of 73 years. These
authors suggested that migraine-associated vasospasm may
have been the cause of sudden deafness.
Migraine is commonly reported in college students, espe-
cially in female students. However, there is no study on the
hearing loss symptoms in this population. The objective of this
study is to determine if changes in hearing occur at higher fre-
quencies in young adultswho suffer frommigraine. Two specific
aims of this study are: 1. To provide evidence regarding whether
hearing loss is a symptom of migraine using extended high
frequency audiometry; 2. To provide evidence demonstrating
utility of extended high frequency air conduction audiometry
and distortion product otoacoustic emissions (DPOAE) in the
diagnosis of cochlear dysfunction in migraine.
2. Materials and methods2.1. SubjectsTen college age individuals (22e26 years old) participated
in this study. All of the participants were recruited from the
New York State University at Buffalo campus. Seven partici-
pants (five females and two males) who suffered from chronic
migraine were recruited as the experimental group. Three
participants who showed no signs of chronic migraine were
recruited for the control group. No significant audiological
issue or noise exposure history was reported by any of the
participants. All of the chronic migraine participants were
asked to complete an additional questionnaire prior to testing
to ensure these criteria was met. Prior to testing, a consent
form was completed by the participants.2.2. Audiologic testingAll audiologic testing was carried out in a sound attenua-
tion booth. Tympanometry was measured using the GSI
TympStar Middle Ear Analyzer. Pure tone air conductionstimuli were delivered through a GSI-61 audiometer. Audio-
metric inclusion criteria for participation in the study were set
as follows: pure-tone air conduction thresholds via insert
earphone transducers at  25 dB HL bilaterally between 250
and 8000 Hz, pure-tone air conduction thresholds via high-
frequency headphone transducers at 0e70 dB HL bilaterally
between 9 and 16 kHz, and normal middle ear pressure and
compliance.2.3. DPOAE testingMeasurement of DPOAEs was carried out using the
SCOUT DPOAE system. The probe was placed in each sub-
ject's right ear, and sealed through a foam ear-tip. Two pure
tone signals, F1 and F2, were simultaneously presented to
record the distortion product 2f1ef2, with parameters that
produced the most robust emission (F2:F1 ¼ 1.2, the intensity
level of F1 is 10 dB higher than F2). F2 frequencies were set at
1797, 2147, 2566, 3080, 3640, 4363, 5133, 6160, 7280, 8726,
10313, 12319, and 14629 Hz. The same trials that were
completed in right ear were then measured in the left ear.
3. Results3.1. Migraine symptomsThe chronic migraine subjects were asked to complete a
questionnaire about their history of migraine. All seven
migraine subjects reported different migraine symptoms, such
as visual or hearing changes, dizziness, fatigue, loss of appetite,
nausea/vomiting, problems concentrating or numbness/weak-
ness (Fig. 1A). In 5 out of the 7 migraine patients, there were
reports of warning symptoms such as eye pain, blurred vision,
seeing stars, tunnel vision or temporary blind spot (Fig. 1B).
Only 3 of the 7 migraine patients reported temporary changes of
hearing that resolved within a few hours from the episode.3.2. Pure tone audiometryAll subjects in both the control group and the migraine
group had pure tone thresholds lower than 25 dB HL from 250
to 8000 Hz. Six out of the fourteen ears in the migraine group
had pure tone thresholds at 25 dB nHL or higher from 9000 to
16000 Hz. The averaged pure tone threshold is graphed in
Fig. 2A. No statistical significant difference was found in the
control group compared with the migraine group (two-way
ANOVA test, P > 0.05). The hearing thresholds at 12 and
16 kHz in individual ears are plotted in Fig. 2B and C,
respectively. Although two ears in the control group showed
thresholds at 30e40 dB HL, the hearing threshold at neither
frequency was statistically significant compared to the
migraine group (Student's t test, P > 0.05).3.3. Distortion product otoacoustic emissions (DPOAEs)Analysis for DPOAE testing was carried out using the
Prism analysis software. A two-way ANOVA with repeated
Fig. 1. (A) Associated symptoms of the test subjects. Common symptoms are visual or hearing changes, dizziness, and fatigue, loss of appetite, nausea/vomiting,
problems concentrating or numbness/weakness. (B) Visual aura warning symptoms, including eye pain, blurred vision, seeing stars, tunnel vision or temporary
blind spot, were also reported.
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the DPOAE amplitude when comparing migraine patients with
the control subjects (P < 0.05) (Fig. 3A). DPOAEs of less than
10 dB SPL were found more often ines the migraine subjects
in comparison with the control subjects (Fig. 3B). A two-sides
Fisher's exact test was statistically significant when individual
ears were compared at suppression levels less than 10 dB
(P < 0.05, Fig. 3C). However, when DPOAE amplitude sup-
pression was compared at 10 kHz, no significant difference
was found (Student's t test, P > 0.05, Fig. 3D). Difference in
length of migraine history was not statistically significant and
it had no impact on DPOAE amplitude (Student's t-test,
Fig. 3E).
4. Discussion
Each participant's hearing was assessed as part of inclusion
criteria in the study. All participants had thresholds of less
than 25 dB HL from 250 to 8000 Hz, indicative of normal
hearing sensitivity. When high frequency audiometricFig. 2. (A) Differences in pure tone audiometry of control subjects versus migrain
subjects at 12 kHz. (C) Pure tone threshold differences between control and migrathresholds were assessed at 9e16 kHz, there was a threshold
increase of up to 40 dB HL in six subjects in the migraine
group. However, the threshold increase in the migraine group
was not statistically significant compared to the control group
due to the large variability of threshold. We also found
significantly reduced DPOAE amplitudes in the migraine
group a 10e16 kHz. Therefore DPOAE is more sensitive to
show early signs of cochlear dysfunction in the migraine
group.
A study by Hamed et al. was published after completion of
this study and assessed patients with migraine using routine
diagnostic audiometry, transient evoked otoacoustic emissions
(TEOAEs), DPOAEs, and auditory brainstem response (ABR).
The data of the study suggest that migraine patients are at high
risk of peripheral and/or central auditory dysfunction. The
study suggests a compromise of blood supply of the auditory
system in migraine patients. In comparison to our current
study, the results are similar in that most of the patients had
normal hearing but did show lowering of DPOAEs, indicating
cochlear or peripheral auditory dysfunction.e subjects. (B) Pure tone threshold differences between control and migraine
ine subjects at 16 kHz.
Fig. 3. (A) Distortion product otoacoustic emissions (DPOAEs) of the control (n ¼ 3) and migraine groups (n ¼ 7). The differences at all frequencies between the
control and the migraine group are statistically significant (two-way ANOVE, P < 0.05). (B) DPOAEs are reduced by less than 10 dB in more migraine subjects
than the control. (C) The number of ears with reduced DPOAEs compared to normal distortion product emissions. (D) Amplitudes of DPOAEs in control and
migraine subjects. The amplitude of DPOAEs in the control subjects show no significant difference compared to migraine subjects at 10 kHz. (E) The length of
migraine history is not relevant to the DPOAE amplitude.
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detect an early sign of hearing loss in migraine patients.
However, high frequency audiometry has no standard norms.
Schechter et al. (Schechter et al., 1986) have studied 157
subjects aged 6e30 years and tried to report normative data of
high-frequency (8e20 kHz) auditory thresholds in normal
hearing individuals. This auditory threshold normative survey
confirmed the gradual reduction of high-frequency sensitivity
from young children until young adulthood. The data suggests
that both intra-age category threshold inconsistency and inter-
aural threshold differences tend to increase with both
increasing age and test frequency. In our study we found a
large variability in the hearing threshold at high frequencies,
despite normal hearing thresholds in the regular range of
audiometry.
OAEs are an objective measure for establishing cochlear
function. OAEs are low level signals that are reflected by
cochlear outer hair cells and are extremely sensitive to outer
hair cell dysfunction. We found reduced amplitude of
DPOAEs in migraine subjects showing hearing thresholds
within normal limits. This result suggests that DPOAEs may
be a better objective measure for early detection of auditory
weakness in patients with migraine.
There are a few significant limitations that are associated
with the outcomes of this study. One of the major short-
comings is the number of subjects who were able to be
tested. The study was not funded which also limited theamount of participants who could be recruited. With only
three participants in the control group and seven in the
experimental group, the ability to generalize results to a
larger population is limited. Future studies in this area should
include more participants to increase the study's external
validity.
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